Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. SOFIDROX CAPSULE 500 MG [SIN11665P]

SOFIDROX CAPSULE 500 MG [SIN11665P]

Active ingredients: SOFIDROX CAPSULE 500 MG

Last updated 26 October 2025

Product Info

SOFIDROX CAPSULE 500 MG

[SIN11665P]

Product information

Active Ingredient and Strength

CEFADROXIL - 500 MG

Dosage Form

CAPSULE

Manufacturer and Country

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD - MALAYSIA

Registration Number

SIN11665P

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

J01DB05

Indications
Infections due to sensitive Gram-positive and Gram-negative bacteria, including those of the biliary, respiratory, urinary tracts and of the skin.

Dosage and Administration
To be administered orally. Adult and children (over 6 years), body weight more than 40 kg:

Urinary Tract Infections:
For acute uncomplicated lower urinary tract infections (e.g. cystitis), the usual daily dosage is 1 or 2 grams per day in a single dose. In complicated or chronic urinary tract infections, the usual dose is 1 g every 12 hours for a minimum of 7 – 10 days.

Skin and Skin Structure Infections:
The usual dosage is 1 gram per day in a single dose.

Upper Respiratory Tract Infections:
The usual dosage is 500 mg every 12 hours. For group A β-haemolytic streptococcal pharyngitis and tonsillitis, 1 gram may be given as a single, daily dose. For any infections caused by Group A β-haemolytic streptococcus, treatment should be administered for 10 days.

Lower Respiratory Tract Infections:
The recommended dosage is 500 mg to 1 gram every 12 hours.

Doses should be reduced in patients with impaired renal function.

Contraindications
Cefadroxil is contraindicated in patients who are sensitive to cephalosporin and in patients with acute porphyria.